Complete Bone Marrow Necrosis with Charcot-Leyden Crystals Caused by Myeloid Neoplasm with Mutated NPM1 and TET2

Intern Med. 2022 Nov 1;61(21):3265-3269. doi: 10.2169/internalmedicine.8859-21. Epub 2022 Feb 19.

Abstract

Bone marrow necrosis (BMN) has various underlying diseases. In hematological malignancies, both lymphoid and myeloid neoplasms have been shown to cause BMN. Charcot-Leyden crystals (CLCs) are bipyramidal crystals that have been found in patients with immune system diseases, tumors, skin diseases, asthma, infections, and intestinal diseases. Because the combination of CLCs and acute myeloid leukemia (AML) is rare, the relationship between BMN, CLCs, and AML remains largely unexplored. We herein report a suspected case of AML that was difficult to diagnose morphologically because of complete BMN with CLCs but achieved complete hematologic remission with treatment similar to that for AML.

Keywords: Charcot-Leyden crystals; acute myeloid leukemia; bone marrow necrosis.

Publication types

  • Case Reports

MeSH terms

  • Bone Marrow / pathology
  • DNA-Binding Proteins
  • Dioxygenases*
  • Humans
  • Leukemia, Myeloid, Acute* / complications
  • Leukemia, Myeloid, Acute* / diagnosis
  • Leukemia, Myeloid, Acute* / genetics
  • Mutation
  • Myeloproliferative Disorders*
  • Necrosis / pathology
  • Nuclear Proteins
  • Remission Induction

Substances

  • Dioxygenases
  • DNA-Binding Proteins
  • Nuclear Proteins
  • TET2 protein, human